Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
COLUMBUS, Ind., June 30, 2015 (GLOBE NEWSWIRE) -- Cummins Inc. (NYSE: CMI) today announced that Dr. John Wall, Vice President – Chief Technical Officer, will be retiring after nearly 30 years...
-
CAMBRIDGE, Mass., June 25, 2015 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
-
Collaboration Combines bluebird bio's Gene Editing and Lentiviral Gene Delivery Technologies and Kite's TCR Capabilities and Exclusive Rights to a TCR Directed Against the HPV-16 E6...
-
CAMBRIDGE, Mass., June 16, 2015 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
-
CAMBRIDGE, Mass., May 14, 2015 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
-
NEW YORK, April 27, 2015 (GLOBE NEWSWIRE) -- As the incidence of type 1 diabetes (T1D) rises worldwide, The Leona M. and Harry B. Helmsley Charitable Trust today announced the launch of an ambitious...
-
Participation and notification of attendance A shareholder, who wishes to participate in the meeting, must (i) be recorded as shareholder (not nominee registered) in the share register held by...
-
WASHINGTON, March 18, 2015 (GLOBE NEWSWIRE) -- BlackRock Inc. and the National Association of Corporate Directors (NACD) today announced the winners of their Global Challenge for Innovation in...
-
WAYNE, Pa., March 5, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Safeguard Scientifics, Inc. (NYSE:SFE) today announced fourth quarter and full-year 2014 financial results. For the three months ended...
-
CAMBRIDGE, Mass., Feb. 27, 2015 (GLOBE NEWSWIRE) -- SAGE Therapeutics (Nasdaq:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-threatening, rare central...